Swirsky Douglas J is a director of Cellectar Biosciences Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
MAXCYTE, INC.
19 Mar 24
4
Cellectar Biosciences, Inc.
28 Jun 23
4
MAXCYTE, INC.
28 Mar 23
3
MAXCYTE, INC.
28 Mar 23
4
Cellectar Biosciences, Inc.
1 Aug 22
4
Cellectar Biosciences, Inc.
14 Sep 21
4
Cellectar Biosciences, Inc.
2 Jul 21
4
NeuroBo Pharmaceuticals, Inc.
3 Sep 20
3
NeuroBo Pharmaceuticals, Inc.
3 Sep 20
4
Cellectar Biosciences, Inc.
25 Jun 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | MXCT MaxCyte | Common Stock | Grant | Acquire A | No | No | 0 | 81,250 | 0.00 | 81,250 |
15 Mar 24 | MXCT MaxCyte | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 4.31 | 225,000 | 969.75 k | 225,000 |
28 Jun 23 | CLRB Cellectar Biosciences | Stock option Common Stock | Grant | Acquire A | No | No | 1.85 | 37,500 | 69.38 k | 71,925 |
27 Mar 23 | MXCT MaxCyte | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 4.11 | 350,000 | 1.44 mm | 350,000 |